Literature DB >> 34893506

Covid-19: Monoclonal antibodies authorised in US as alternative to vaccines for certain groups.

Zosia Kmietowicz1.   

Abstract

Entities:  

Year:  2021        PMID： 34893506     DOI： 10.1136/bmj.n3064

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2.

Authors:  Fakry F Mohamed; Darisuren Anhlan; Michael Schöfbänker; André Schreiber; Nica Classen; Andreas Hensel; Georg Hempel; Wolfgang Scholz; Joachim Kühn; Eike R Hrincius; Stephan Ludwig
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-25

Review 2.  Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).

Authors:  Simone Cesaro; Per Ljungman; Malgorzata Mikulska; Hans H Hirsch; Marie von Lilienfeld-Toal; Catherine Cordonnier; Sylvain Meylan; Varun Mehra; Jan Styczynski; Francesco Marchesi; Caroline Besson; Fausto Baldanti; Raul Cordoba Masculano; Gernot Beutel; Herman Einsele; Elie Azoulay; Johan Maertens; Rafael de la Camara; Livio Pagano
Journal:  Leukemia       Date:  2022-04-29       Impact factor: 12.883

3.  Tixagevimab and Cilgavimab: Can we see More Recommendations for Monoclonal Antibodies Beyond COVID-19 Vaccination.

Authors:  Al-Taie Anmar
Journal:  Disaster Med Public Health Prep       Date:  2022-06-08       Impact factor: 5.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.